ACADIA Pharmaceuticals IncEigentümerstruktur
| Preis (2026-07-30) | 52W Hoch | 52W Tief |
| 26.55 USD | 28,35 USD | 19,69 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 32,95 USD | 7 | 6 | 6 | 1 | 0 |
| #Shares | Short [%] | Short Ratio |
| 171.235.870 | 10,22 | 5,9 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name ACADIA Pharmaceuticals Inc
Mitarbeiter 796
Handelsplatz NASDAQ
Ticker Symbol ACAD
IPO Datum 2004-05-27
Adresse 12830 El Camino Real, San Diego, CA, United States, 92130
Webseite https://www.acadia.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Ms. Catherine E. Owen Adams | CEO & Director |
| 2 | Mr. Mark C. Schneyer | Executive VP & CFO |
| 3 | Ms. Jennifer J. Rhodes J.D. | Executive VP, Chief Legal Officer & Secretary |
| 4 | Dr. Elizabeth H. Z. Thompson Ph.D. | Executive VP and Head of Research & Development |
| 5 | Mr. Thomas Andrew Garner | Executive VP & Chief Commercial Officer |
| 6 | Mr. Scott Cenci | Senior VP, Chief Information & Data Officer |
| 7 | Mr. Albert S. Kildani | Senior Vice President of Investor Relations & Corporate Communications |
| 8 | Mr. Carl Segerstrom | Chief People Officer |
| 9 | Mr. James K. Kihara | Senior Vice President of Finance |
| 10 | Ms. Allyson McMillan-Youngblood | Senior Vice President of Rare Disease Franchise |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Baker Bros Advisors LP | 0,00% | 0,00 Mio. USD |
| 2 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 3 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 4 | Vanguard Portfolio Management, LLC | 0,00% | 0,00 Mio. USD |
| 5 | State Street Corp | 0,00% | 0,00 Mio. USD |
| 6 | RTW INVESTMENTS, LLC | 0,00% | 0,00 Mio. USD |
| 7 | Vanguard Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 8 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 9 | First Trust Advisors L.P. | 0,00% | 0,00 Mio. USD |
| 10 | Dimensional Fund Advisors, Inc. | 0,00% | 0,00 Mio. USD |
| 11 | Palo Alto Investors, LLC | 0,00% | 0,00 Mio. USD |
| 12 | Point72 Asset Management, L.P. | 0,00% | 0,00 Mio. USD |
| 13 | BRAIDWELL LP | 0,00% | 0,00 Mio. USD |
| 14 | Pictet Asset Manangement SA | 0,00% | 0,00 Mio. USD |
| 15 | Renaissance Technologies Corp | 0,00% | 0,00 Mio. USD |
| 16 | Arrowstreet Capital Limited Partnership | 0,00% | 0,00 Mio. USD |
| 17 | The Goldman Sachs Group Inc | 0,00% | 0,00 Mio. USD |
| 18 | Bank of America Corp | 0,00% | 0,00 Mio. USD |
| 19 | NORGES BANK | 0,00% | 0,00 Mio. USD |
| 20 | Frazier Life Sciences Management, L.P. | 0,00% | 0,00 Mio. USD |